SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Investment analysts at Sidoti cut their Q1 2026 earnings per share (EPS) estimates for shares of SBC Medical Group in a research note issued on Wednesday, April 1st. Sidoti analyst A. Shah now forecasts that the company will earn $0.10 per share for the quarter, down from their prior forecast of $0.11. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Sidoti also issued estimates for SBC Medical Group's Q2 2026 earnings at $0.12 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS, FY2026 earnings at $0.47 EPS, Q1 2027 earnings at $0.12 EPS, Q2 2027 earnings at $0.13 EPS, Q3 2027 earnings at $0.13 EPS, Q4 2027 earnings at $0.13 EPS and FY2027 earnings at $0.52 EPS.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last released its quarterly earnings results on Friday, March 27th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. SBC Medical Group had a net margin of 29.37% and a return on equity of 20.76%. The firm had revenue of $39.57 million for the quarter, compared to analysts' expectations of $45.19 million.
SBC has been the subject of a number of other reports. BTIG Research started coverage on shares of SBC Medical Group in a research note on Friday, March 6th. They issued a "buy" rating and a $8.00 price target for the company. Weiss Ratings reissued a "sell (d+)" rating on shares of SBC Medical Group in a report on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $8.50.
Read Our Latest Stock Report on SBC Medical Group
SBC Medical Group Stock Up 5.3%
SBC stock opened at $4.40 on Thursday. SBC Medical Group has a fifty-two week low of $2.91 and a fifty-two week high of $5.75. The company has a market capitalization of $451.34 million, a price-to-earnings ratio of 8.98 and a beta of 0.99. The business's 50 day moving average price is $4.12 and its two-hundred day moving average price is $4.04. The company has a debt-to-equity ratio of 0.13, a quick ratio of 5.06 and a current ratio of 3.78.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in SBC. Goldman Sachs Group Inc. purchased a new position in shares of SBC Medical Group during the 4th quarter valued at approximately $49,000. Russell Investments Group Ltd. boosted its stake in SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company's stock worth $51,000 after purchasing an additional 8,771 shares during the last quarter. Nuveen LLC purchased a new stake in shares of SBC Medical Group during the fourth quarter worth $53,000. Wells Fargo & Company MN raised its position in shares of SBC Medical Group by 195.1% in the fourth quarter. Wells Fargo & Company MN now owns 12,626 shares of the company's stock valued at $54,000 after buying an additional 8,348 shares during the last quarter. Finally, XTX Topco Ltd purchased a new position in shares of SBC Medical Group in the second quarter worth about $64,000. 60.82% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of the business's stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $2.12, for a total transaction of $9,376,548.00. Following the completion of the transaction, the chief executive officer owned 861,600 shares in the company, valued at $1,826,592. The trade was a 83.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 89.47% of the stock is currently owned by insiders.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.
The company's primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
